Dacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): pooled subset analyses from two randomized trials
Ann Oncol
.
2016 Jul;27(7):1363.
doi: 10.1093/annonc/mdw221.
Epub 2016 May 30.
Authors
S S Ramalingam
,
K O'Byrne
,
M Boyer
,
T Mok
,
P A Jänne
,
H Zhang
,
J Liang
,
I Taylor
,
E I Sbar
,
L Paz-Ares
PMID:
27240994
DOI:
10.1093/annonc/mdw221
No abstract available
Publication types
Published Erratum